Nationalität
USA

Geburtsjahr
1973

1995
George Washington University, Washington, DC, BBA

2005–2007
Genentech, Senior Product Manager

2007–2010
Genentech, Group Product Manager / Associate Director GIO Pipeline Strategy & Operations

2010
Genentech, Divisional Sales Manager

2011–2012
Genentech, Marketing Director, Rituxan Immunologie

2012–2013
Genentech, Marketing Director, ACTEMRA

2013–2015
Genentech, Senior Director, Field Reimbursement Management

2015–2017
Roche Pharmaceuticals Basel. Lifecycle Leader. ACTEMRA

2017
Genentech, Vice President, Rheumatology / Nephrology

2018–2019
Genentech, Vice President, Avastin, Alecensa, Tarceva and Entrectinib, Lunge & GI Onkologie Sales

2019–2023
Roche Pharma Basel, Leiterin Globale Produktstrategie

Seit März 2023
Roche Pharma Basel, CEO, Mitglied der Konzernleitung

Seit 2022
Spark Therapeutics, Inc., Mitglied des Verwaltungsrats

Seit 2023
EFPIA,  Mitglied des Verwaltungsrats

Seit 2023
Flatiron Health Inc., Mitglied des Verwaltungsrats

Seit 2003
Chugai Pharmaceutical Co., Ltd, Mitglied des Verwaltungsrats


This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.